RxDoctor Payments Data

Neil Strauss

Foot & Ankle Surgery · Tamarac, FLNPI 1053319145

Payments from drug & device makers

What this record shows

This record is dominated by other: $29,930 of the $33,109 with a category attached, or 90.4%. Skye Orthobiologics LLC accounts for 90.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $30,192 and has fallen 99.6% since, to $111 in 2025. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,109in general payments, 2019–2025

Across 79 payments — averaging $419.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Skye Orthobiologics LLC$30K
  • Stryker$743
  • Smith+Nephew$487
  • Integra Lifesciences Corporation$389
  • Amgen$250
  • Kerecis Limited$219
  • plus $1K from 12 others
$94,735in research payments, 2019–2025

Across 17 payments — averaging $5572.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$56K
  • Osiris Therapeutics Inc.$39K

What the payments were for

  • Food & beverage$3,17910%
  • Other$29,93090%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,109 in reported general payments places this provider in the 90th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$2,136,746
Medicare patients
367
Services billed
3,911

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate64$1,625
Clobetasol Propionate16$976
Ammonium Lactate53$567
Gabapentin27$453
Ciclopirox18$375
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip22$238
Ciprofloxacin Hcl32$227
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$195
Doxycycline Hyclate29$170
Celecoxib17$87
Methylprednisolone12$78
Tramadol Hcl22$66
Triamcinolone Acetonide23$65

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Tamarac

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →